pCS2_IRES2_CyOFP1_KCNQ2 var4
(Plasmid
#173155)
-
PurposeFor mammalian expression of KCNQ2 and creating variants
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 173155 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCS2_IRES2_CyOFP1
- Backbone size w/o insert (bp) 5671
- Total vector size (bp) 8197
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameKCNQ2
-
Alt nameKv7.2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2526
-
Entrez GeneKCNQ2 (a.k.a. BFNC, DEE7, EBN, EBN1, ENB1, HNSPC, KCNA11, KV7.2)
- Promoter Simian CMV IE94
-
Tag
/ Fusion Protein
- IRES2-CyOFP1 (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer CMV_F
- 3′ sequencing primer SV40pA_R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCS2_IRES2_CyOFP1_KCNQ2 var4 was a gift from Al George (Addgene plasmid # 173155 ; http://n2t.net/addgene:173155 ; RRID:Addgene_173155) -
For your References section:
Dyshomeostatic modulation of Ca(2+)-activated K(+) channels in a human neuronal model of KCNQ2 encephalopathy. Simkin D, Marshall KA, Vanoye CG, Desai RR, Bustos BI, Piyevsky BN, Ortega JA, Forrest M, Robertson GL, Penzes P, Laux LC, Lubbe SJ, Millichap JJ, George AL Jr, Kiskinis E. Elife. 2021 Feb 5;10. pii: 64434. doi: 10.7554/eLife.64434. 10.7554/eLife.64434 PubMed 33544076